Tibra Equities Europe’s Gilead Sciences GILD Stock Holding History

Tibra Equities Europe’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-35,030	Closed	-$2.04M	–	53
2020 Q4	$2.04M	Buy	+35,030	New	+$2.11M	0.21%	58
2019 Q2	–	Sell	-25,200	Closed	-$1.64M	–	322
2019 Q1	$1.64M	Sell	25,200 -10,600	-30%	-$705K	0.16%	118
2018 Q4	$2.24M	Buy	+35,800	New	+$2.5M	0.37%	53

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Tibra Equities Europe's GILD Position: Q1 2021 in Review

Tibra Equities Europe sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 35,030 shares — an estimated $2.04M sold.

Tibra Equities Europe first reported a position in GILD in Q4 2018 and held it in 3 quarters. The position peaked at $2.24M in Q4 2018. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

Tibra Equities Europe reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
Tibra Equities Europe sold 35,030 Gilead Sciences shares in Q1 2021, an estimated $2.04M.
Tibra Equities Europe first reported a position in Gilead Sciences in Q4 2018 and held it in 3 quarters.
Tibra Equities Europe's Gilead Sciences position peaked at $2.24M in Q4 2018.
1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Tibra Equities Europe's 13F filing for Q1 2021, filed 17 May 2021.